Association between low-dose acetylsalicylic acid reinitiation and the risk of myocardial infarction or coronary heart disease death
Conclusions
ASA reinitiation was not associated with a decreased risk of myocardial infarction/coronary heart disease death. This may be explained by confounding by indication/comorbidity, whereby higher-risk patients are more likely to reinitiate therapy. An additional period of ASA discontinuation among reinitiators was associated with an increased risk of myocardial infarction/coronary heart disease death.
Source: European Journal of Preventive Cardiology - Category: Cardiology Authors: Saez, M. E., Gonzalez-Perez, A., Johansson, S., Himmelmann, A., Garcia Rodriguez, L. A. Tags: Original scientific papers Source Type: research
More News: Cardiology | Cardiovascular | Coronary Heart Disease | Health | Heart | Heart Attack | Heart Disease | Study